Author + information
- Received May 30, 2008
- Revision received August 27, 2008
- Accepted September 5, 2008
- Published online November 1, 2008.
- Luis C. Afonso, MD, FACC⁎,
- Juan Bernal, MD⁎,
- Jeroen J. Bax, MD† and
- Theodore P. Abraham, MD, FACC‡,⁎ ()
Reprint requests and correspondence:
Dr. Theodore P. Abraham, Johns Hopkins University, 600 North Wolfe Street, Carnegie 568, Baltimore, Maryland 21287
Hypertrophic cardiomyopathy is a relatively common inherited cardiomyopathy that is occasionally challenging to differentiate from hypertensive heart disease and athlete hearts on the basis of morphologic or functional abnormalities alone. Echocardiography has traditionally played a preeminent role in the diagnosis, formulation of management strategies, and the prognostication of this complex disease. In this review, we briefly profile the utility and pitfalls of established echocardiographic modalities and discuss the evolving role of novel echocardiographic imaging modalities such as tissue Doppler, Doppler-based strain, 2-dimensional strain (speckle tracking imaging), and 3-dimensional imaging in the assessment of hypertrophic cardiomyopathy.
- Received May 30, 2008.
- Revision received August 27, 2008.
- Accepted September 5, 2008.
- American College of Cardiology Foundation